vimarsana.com

Page 106 - குறிப்பு தொடர்பாக முன்னோக்கி பார்க்கிறது அறிக்கைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Northern Vertex Drills Further Widespread Mineralized Intercepts Along The Ruth Vein, Parallel to Moss Mine Open Pit

Share: Highlights: 15.25 meters @ 3.35 g/t gold and 23.09 g/t silver within 33.55 meters @ 1.83 g/t gold and 13.49 g/t silver in hole AR20-350R 1.5 meters @ 8.74 g/t gold and 80.10 g/t silver in hole AR20-322R, which is 183 meters east of AR20-350R 3.0 meters @ 3.82 g/t gold and 56.0 g/t silver in hole AR20-321R, which is 457 meters east of AR20-350R Results are from the Ruth vein, 160 meters south of, and parallel to, Moss Mine open pit VANCOUVER, BC, Dec. 10, 2020 /CNW/ -  Northern Vertex Mining Corp. (TSXV:NEE) (OTC Nasdaq Intl.: NHVCF) (the Company or Northern Vertex ) is pleased to announce recent drill results from its multi-phase drilling and resource expansion program (the Program ) at the Moss Mine in NW Arizona.  The most notable results are set out above and are taken from 37 new reverse circulation(RC) drill holes from the Ruth vein area, which hosts multiple high-grade zones within larger zones of typical Moss Mine bulk-tonnage grade mineralization along t

Gatekeeper Systems Inc : Gatekeeper Reports $20 3M Revenue, $3 5M Net Income, $0 04 EPS in Record Breaking Fiscal 2020

Gatekeeper Systems Inc.: Gatekeeper Reports $20.3M Revenue, $3.5M Net Income, $0.04 EPS in Record Breaking Fiscal 2020 Abbotsford, British Columbia (Newsfile Corp. - December 10, 2020) - Gatekeeper Systems Inc. (TSXV: GSI) (OTC Pink: GKPRF) (FSE: 1GK) ( Gatekeeper or the Company ), a video and data solutions provider for public transportation and smart cities, reports audited financial results for fiscal year ended August 31, 2020. Fourth Quarter and Year End Highlights Revenue for the year ended August 31, 2020 was $20,316,576, the highest fiscal year revenue in the Company s history and an increase of 48% when compared to $13,726,313 for the same period in the previous year; Revenue for the fourth quarter was

ObsEva Announces Additional Phase 3 PRIMROSE 1 and 2 Study Results Confirming Sustained Efficacy and Continued Safety of linzagolix in the Treatment of Uterine Fibroids – IT Business Net

ObsEva Announces Additional Phase 3 PRIMROSE 1 and 2 Study Results Confirming Sustained Efficacy and Continued Safety of linzagolix in the Treatment of Uterine Fibroids – IT Business Net
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.